Overview

The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients

Status:
Completed
Trial end date:
2017-02-14
Target enrollment:
Participant gender:
Summary
This study assessed the effect of tailored eradication therapy according to Clarithromycin resistance in Helicobacter pylori patients.
Phase:
Phase 4
Details
Lead Sponsor:
Kyungpook National University
Kyungpook National University Hospital
Treatments:
Amoxicillin
Clarithromycin
Metronidazole